Hendriksen Coenraad, Arciniega Juan L, Bruckner Lukas, Chevalier Michel, Coppens Emmanuelle, Descamps Johan, Duchêne Michel, Dusek David Michael, Halder Marlies, Kreeftenberg Hans, Maes Alexandrine, Redhead Keith, Ravetkar Satish D, Spieser Jean-Marc, Swam Hanny
Netherlands Vaccine Institute, A. van Leeuwenhoeklaan 11, 3720 AL Bilthoven, The Netherlands.
Biologicals. 2008 Jan;36(1):73-7. doi: 10.1016/j.biologicals.2007.05.002. Epub 2007 Sep 24.
Current lot release testing of conventional vaccines emphasizes quality control of the final product and is characterized by its extensive use of laboratory animals. This report, which is based on the outcome of an ECVAM (European Centre for Validation of Alternative Methods, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra, Italy) workshop, discusses the concept of consistency testing as an alternative approach for lot release testing. The consistency approach for the routine release of vaccines is based upon the principle that the quality of vaccines is a consequence of a quality system and of consistent production of lots with similar characteristics to those lots that have been shown to be safe and effective in humans or the target species. The report indicates why and under which circumstances this approach can be applied, the role of the different stakeholders, and the need for international harmonization. It also gives recommendations for its implementation.
传统疫苗当前的批次放行检测强调最终产品的质量控制,其特点是大量使用实验动物。本报告基于欧洲替代方法验证中心(ECVAM,位于意大利伊斯普拉的欧盟委员会联合研究中心健康与消费者保护研究所)一次研讨会的成果,讨论了一致性检测这一批次放行检测替代方法的概念。疫苗常规放行的一致性方法基于这样的原则,即疫苗质量是质量体系以及与已证实在人体或目标物种中安全有效的批次具有相似特征的批次持续生产的结果。该报告指出了采用此方法的原因和适用情形、不同利益相关者的作用以及国际协调的必要性。它还给出了实施该方法的建议。